Nerve compression activates selective nociceptive pathways and upregulates peripheral sodium channel expression in schwann cells

Journal of Orthopaedic Research

Volumn 28, Issue 6, 2010, Pages 753-761

  Frieboes, Laura Rummler ^a   Palispis, Winnie Anne ^a   Gupta, Ranjan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C fos; Carpal tunnel syndrome; IL 6; Nav1.8; Schwann cell; TNF

Indexed keywords

INTERLEUKIN 6; SODIUM CHANNEL NAV1.8; TUMOR NECROSIS FACTOR ALPHA; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CHRONIC NERVE COMPRESSION; HUMAN; IN VIVO STUDY; INFLAMMATION; MALE; NERVE COMPRESSION; NERVE FIBER; NEUROPATHIC PAIN; NONHUMAN; ONCOGENE C FOS; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHWANN CELL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; CHRONIC DISEASE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN-6; MALE; NERVE COMPRESSION SYNDROMES; NERVE TISSUE PROTEINS; PAIN; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SCHWANN CELLS; SODIUM CHANNELS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 77951456829     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21047     Document Type: Article

References (50)

1. Ko C, Brown TD. 2007. A fluid-immersed multi-body contact finite element formulation for median nerve stress in the carpal tunnel. Comput Methods Biomech Biomed Eng 10:343-349.
2. Hybbinette CH, Mannerfelt L. 1975. The carpal tunnel syndrome. A retrospective study of 400 operated patients. Acta Orthop Scand 46:610-620.
3. Ng LC, Tafazal S, Sell P. 2007. The effect of duration of symptoms on standard outcome measures in the surgical treatment of spinal stenosis. Eur Spine J 16:199-206. (Pubitemid 46295200)
4. Padua L, Padua R, Aprile I, et al. 2001. Multiperspective follow-up of untreated carpal tunnel syndrome: a multicenter study. Neurology 56:1459-1466. (Pubitemid 32532257)
5. Semple JC, Cargill AO. 1969. Carpal-tunnel syndrome. Results of surgical decompression. Lancet 1:918-919.
6. Phalen GS. 1966. The carpal-tunnel syndrome. Seventeen years' experience in diagnosis and treatment of six hundred fifty-four hands. J Bone Joint Surg [Am] 48:211-228.
7. Spinner RJ, Bachman JW, Amadio PC. 1989. The many faces of carpal tunnel syndrome. Mayo Clin Proc 64:829-836. (Pubitemid 19230652)
8. Gupta R, Steward O. 2003. Chronic nerve compression induces concurrent apoptosis and proliferation of Schwann cells. J Comp Neurol 461:174-186. (Pubitemid 36583461)
9. Mackinnon SE, Dellon AL, Hudson AR, et al. 1984. Chronic nerve compression - an experimental model in the rat. Ann Plast Surg 13:112-120. (Pubitemid 14049833)
10. Mackinnon SE, Dellon AL, Hudson AR, et al. 1986. Chronic human nerve compression - a histological assessment. Neuropathol Appl Neurobiol 12:547-565. (Pubitemid 17010648)
11. Gupta R, Rummler LS, Palispis W, et al. 2006. Local down-regulation of myelin-associated glycoprotein permits axonal sprouting with chronic nerve compression injury. Exp Neurol 200:418-429. (Pubitemid 44131534)
12. Hartung HP. 1993. Immune-mediated demyelination. Ann Neurol 33:563-567.
13. Wagner R, Myers RR. 1996. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 73:625-629. (Pubitemid 26260924)
14. Wang Y, Zhou D, Shen Q, et al. 2007. Lipopolysaccharide-induced upregulation of tumor necrosis factor-alpha (TNF-alpha) and TNF receptors in rat sciatic nerve. J Mol Neurosci 32:207-216. (Pubitemid 47574969)
15. Watkins LR, Maier SF. 1999. Cytokines and pain Basel; Boston: Birkhauser Verlag.
16. Bolin LM, Verity AN, Silver JE, et al. 1995. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem 64:850-858.
17. Bourde O, Kiefer R, Toyka KV, et al. 1996. Quantification of interleukin-6 mRNA in Wallerian degeneration by competitive reverse transcription polymerase chain reaction. J Neuroimmunol 69:135-140. (Pubitemid 26305638)
18. Cunha FQ, Poole S, Lorenzetti BB, et al. 1992. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 107:660-664.
19. Sommer C. 2001. Pain in peripheral nerve diseases Basel; New York: Karger.
20. Sommer C, Schmidt C, George A. 1998. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp Neurol 151:138-142. (Pubitemid 28223862)
21. Wagner R, Myers RR, O'Brien JS. 1998. Prosaptide prevents hyperalgesia and reduces peripheral TNFR1 expression following TNF-alpha nerve injection. Neuroreport 9:2827-2831. (Pubitemid 28435171)
22. Watkins LR, Goehler LE, Relton J, et al. 1995. Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res 692:244-250.
23. Hunt SP, Pini A, Evan G. 1987. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 328:632-634. (Pubitemid 17103967)
24. Cummins TR, Dib-Hajj SD, Black JA, et al. 1999. A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons. J Neurosci 19:RC43.
25. Porreca F, Lai J, Bian D, et al. 1999. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc Natl Acad Sci USA 96:7640-7644.
26. Rogers M, Tang L, Madge DJ, et al. 2006. The role of sodium channels in neuropathic pain. Semin Cell Dev Biol 17:571-581. (Pubitemid 46110815)
27. Khasar SG, Gold MS, Levine JD. 1998. A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat. Neurosci Lett 256:17-20.
28. Coward K, Plumpton C, Facer P, et al. 2000. Immunolocalization of SNS/PN3 and NaN/SNS2 sodium channels in human pain states. Pain 85:41-50. (Pubitemid 30110742)
29. Novakovic SD, Tzoumaka E, McGivern JG, et al. 1998. Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions. J Neurosci 18:2174-2187. (Pubitemid 28141422)
30. Yiangou Y, Birch R, Sangameswaran L, et al. 2000. SNS/PN3 and SNS2/NaN sodium channel-like immunoreactivity in human adult and neonate injured sensory nerves. FEBS Lett 467:249-252. (Pubitemid 30081744)
31. Siconolfi LB, Seeds NW. 2001. Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush. J Neurosci 21:4348-4355.
32. Waibl H. 1973. Zur topographie der medulla spinalis der albinoratte (Rattus norvegicus) Berlin; New York: Springer-Verlag
33. Hebel R, Stromberg MW, Hebel R. 1986. Anatomy and embryology of the laboratory rat. Wörthsee Germany: BioMed Verlag.
34. Molander C, Xu Q, Grant G. 1984. The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. J Comp Neurol 230:133-141. (Pubitemid 15221509)
35. Shubayev VI, Myers RR. 2001. Axonal transport of TNF-alpha in painful neuropathy: distribution of ligand tracer and TNF receptors. J Neuroimmunol 114:48-56.
36. Brockes JP, Raff MC. 1979. Studies on cultured rat Schwann cells. II. Comparison with a rat Schwann cell line. In Vitro 15:772-778. (Pubitemid 10170783)
37. Presley RW, Menetrey D, Levine JD, Basbaum AI. 1990. Systemic morphine suppresses noxious stimulus-evoked fos protein-like immunoreactivity in the rat spinal cord. J Neurosci 10:323-325. (Pubitemid 20059269)
38. Gupta R, Channual JC. 2006. Spatiotemporal pattern of macrophage recruitment after chronic nerve compression injury. J Neurotrauma 23:216-226.
39. Bester H, Beggs S, Woolf C. 2000. Changes in tactile stimuli-induced behavior and c-fos expression in the superficial dorsal horn and in parabrachial nuclei after sciatic nerve crush. J Comp Neurol 428:45-61.
40. Buritova J, Besson JM, Bernard JF. 1998. Involvement of the spinoparabrachial pathway in inflammatory nociceptive processes: a c-fos protein study in the awake rat. J Comp Neurol 397:10-28. (Pubitemid 28304049)
41. Jasmin L, Wang H, Tarczy-Hornoch K, et al. 1994. Differential effects of morphine on noxious stimulus-evoked fos-like immunoreactivity in subpopulations of spinoparabrachial neurons. J Neurosci 14:7252-7260. (Pubitemid 24379737)
42. Boucher TJ, Okuse K, Bennett DL, et al. 2000. Potent analgesic effects of GDNF in neuropathic pain states. Science 290:124-127.
43. Wang R, Guo W, Ossipov MH, et al. 2003. Glial cell line-derived neurotrophic factor normalizes neurochemical changes in injured dorsal root ganglion neurons and prevents the expression of experimental neuropathic pain. Neuroscience 121:815-824. (Pubitemid 38367518)
44. Chao T, Pham K, Steward O, et al. 2008. Chronic nerve compression injury induces a phenotypic switch of neurons within the dorsal root ganglia. J Comp Neurol 506:180-193.
45. Devor M 2006. Sodium channels and mechanisms of neuropathic pain. J Pain 7:S3-S12. (Pubitemid 43106683)
46. Govrin-Lippmann R, Devor M. 1978. Ongoing activity in severed nerves: source and variation with time. Brain Res 159:406-410. (Pubitemid 9050975)
47. Devaux JJ, Scherer SS. 2005. Altered ion channels in an animal model of Charcot-Marie-Tooth disease type IA. J Neurosci 25:1470-1480. (Pubitemid 40250723)
48. Ulzheimer JC, Peles E, Levinson SR, et al. 2004. Altered expression of ion channel isoforms at the node of Ranvier in P0-deficient myelin mutants. Mol Cell Neurosci 25:83-94. (Pubitemid 38220866)
49. Liu HM, Yang LH, Yang YJ. 1995. Schwann cell properties: 3. C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration. J Neuropathol Exp Neurol 54:487-496.
50. Scholz J, Woolf CJ. 2007. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10:1361-1368. (Pubitemid 350014681)